Literature DB >> 2703140

Statistical analysis of the lactulose/breath hydrogen test in the measurement of orocaecal transit: its variability and predictive value in assessing drug action.

D H Staniforth1, D Rose.   

Abstract

The variability in the orocaecal transit time as measured by the lactulose/breath hydrogen method has been studied for three conditions: lactulose given with a meal, subjects sitting; lactulose given with a meal, subjects semirecumbent; lactulose given in aqueous solution, subjects semirecumbent. Thirty three healthy subjects attended on up to 12 occasions. It was found that administration of the lactulose with a meal significantly reduced the variability (p less than 0.05) and that adoption of the semirecumbent position further reduced variability. A power analysis was used to predict the number of subjects who would be required to show a given percentage change in orocaecal transit time at specified probabilities and powers. A graph and a table for use in the prediction of subject numbers at a probability of 5% and for powers of 50-99% is presented. A dose response curve for metoclopramide using the lactulose/breath hydrogen method is given for doses of 10, 15, and 20 mg.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2703140      PMCID: PMC1378297          DOI: 10.1136/gut.30.2.171

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  6 in total

1.  Use of breath hydrogen (H2) to quantitate small bowel transit time following partial gastrectomy.

Authors:  J H Bond; M D Levitt
Journal:  J Lab Clin Med       Date:  1977-07

2.  Assessment of the reproducibility of the lactulose H2 breath test as a measure of mouth to caecum transit time.

Authors:  S J La Brooy; P J Male; A K Beavis; J J Misiewicz
Journal:  Gut       Date:  1983-10       Impact factor: 23.059

3.  Pulmonary hydrogen and methane and plasma ammonia after the administration of lactulose or sorbitol.

Authors:  J Beaven; A Bjørneklett; E Jenssen; J P Blomhoff; S Skrede
Journal:  Scand J Gastroenterol       Date:  1983-05       Impact factor: 2.423

4.  A pharmacological method of measuring mouth caecal transit time in man.

Authors:  M Kennedy; P Chinwah; D N Wade
Journal:  Br J Clin Pharmacol       Date:  1979-10       Impact factor: 4.335

5.  Investigation of small bowel transit time in man utilizing pulmonary hydrogen (H2) measurements.

Authors:  J H Bond; M D Levitt; R Prentiss
Journal:  J Lab Clin Med       Date:  1975-04

6.  Effect of drugs on oro-caecal transit time assessed by the lactulose/breath hydrogen method.

Authors:  D H Staniforth
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

  6 in total
  15 in total

1.  Effect of erythromycin on the oro-caecal transit time in man.

Authors:  J Lehtola; P Jauhonen; A Kesäniemi; R Wikberg; A Gordin
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Role of fasting gastrointestinal motility in the variability of gastrointestinal transit time assessed by hydrogen breath test.

Authors:  C Di Lorenzo; C P Dooley; J E Valenzuela
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

3.  Comparison of scintigraphy and lactulose breath hydrogen test for assessment of orocecal transit: lactulose accelerates small bowel transit.

Authors:  M A Miller; H P Parkman; J L Urbain; K L Brown; D J Donahue; L C Knight; A H Maurer; R S Fisher
Journal:  Dig Dis Sci       Date:  1997-01       Impact factor: 3.199

4.  A radiopaque marker technique for measuring gastrointestinal transit in subjects with an ileostomy.

Authors:  P A Goldberg; M A Kamm; R J Nicholls
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

5.  Meta-analysis of oro-cecal transit time in fasting subjects.

Authors:  Tohru Kokubo; Shigeyuki Matsui; Makio Ishiguro
Journal:  Pharm Res       Date:  2012-09-28       Impact factor: 4.200

6.  The effect of short-term dietary fibre administration on oro-caecal transit time in dogs.

Authors:  K Papasouliotis; P Muir; T J Gruffydd-Jones; P J Cripps; A C Blaxter
Journal:  Diabetologia       Date:  1993-03       Impact factor: 10.122

7.  Use of breath hydrogen measurement to evaluate orocecal transit time in cats before and after treatment for hyperthyroidism.

Authors:  D P Schlesinger; S I Rubin; M G Papich; D L Hamilton
Journal:  Can J Vet Res       Date:  1993-04       Impact factor: 1.310

8.  Loperamide abolishes exercise-induced orocecal liquid transit acceleration.

Authors:  W F Keeling; A Harris; B J Martin
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

9.  Human pharmacology of renzapride: a new gastrokinetic benzamide without dopamine antagonist properties.

Authors:  D H Staniforth; M Pennick
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

10.  Lactulose hydrogen breath test in orocecal transit assessment. Critical evaluation by means of scintigraphic method.

Authors:  G Sciarretta; A Furno; M Mazzoni; B Garagnani; P Malaguti
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.